[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349382-105":59,"doc-detail-349382-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","advances-in-sec61g-research-from-er-translocon-subunit-to-emerging-pan-cancer-oncogenic-roles","Advances in SEC61G research - from ER translocon subunit to emerging pan-cancer oncogenic roles","","SEC61G, the γ subunit of the Sec61 translocon, is reviewed as an EGFR-associated co-amplification passenger that also acts as an independent oncogenic driver across multiple cancers. A mechanism-based framework classifies SEC61G activities into canonical immune-checkpoint regulation, aberrant calcium signaling, and noncanonical, channel-independent mechanisms. The review maps pan-cancer expression and CRISPR-Cas9 dependency, emphasizing a high-expression/high-dependency profile in cervical squamous cell carcinoma, compares pore-targeting Sec61 inhibitors with subunit-specific strategies, and proposes PROTAC degraders and PPI inhibitors. SEC61G is presented as a pan-cancer prognostic biomarker and immunotherapy-response predictor supported by mechanistic evidence in glioblastoma, non-small cell lung cancer, and colorectal cancer.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/advances-in-sec61g-research-from-er-translocon-subunit-to-emerging-pan-cancer-oncogenic-roles/349382/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/advances-in-sec61g-research-from-er-translocon-subunit-to-emerging-pan-cancer-oncogenic-roles/349382.png","ImageObject",300,407,{"name":92,"@type":93},"Kurz","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is SEC61G and why is it important in cancer biology?","Question",{"text":112,"@type":113},"SEC61G is the γ subunit of the Sec61 translocon. It has been linked to independent oncogenic functions across multiple cancers, not just as an EGFR co-amplification passenger.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does the review classify SEC61G oncogenic mechanisms?",{"text":117,"@type":113},"It groups SEC61G activities into canonical immune checkpoint regulation via translocation, aberrant calcium signaling, and noncanonical mechanisms independent of channel functions.",{"name":119,"@type":110,"acceptedAnswer":120},"What evidence does the review provide for SEC61G as a biomarker?",{"text":121,"@type":113},"The review highlights pan-cancer expression and CRISPR-Cas9 dependency, and describes mechanistic evidence supporting SEC61G as a prognostic biomarker and immunotherapy response predictor in glioblastoma, non-small cell lung cancer, and colorectal cancer.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},349382,1790236809,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336478945635,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","CANCER BIOLOGY & THERAPY 2026, VOL. 27, NO. 1, 2694136  \n[https://doi.org/10.1080/15384047.2026.2694136](https://doi.org/10.1080/15384047.2026.2694136)  \nREVIEW ARTICLE     \nAdvances in SEC61G research: from ER translocon subunit to emerging pan-cancer oncogenic roles  \nYu-Nan Man 1  and Mao-Lin He   \nDivision of Spinal Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, People's Republic of China  \nABSTRACT  \nSEC61G, the γ subunit of the Sec61 translocon, has long been regarded as a passenger co-amplification target of EGFR on chromosome 7p11.2 . Recent studies have revealed its independent oncogenic functions across multiple cancers. This review proposes a mechanism-based classification of SEC61G oncogenic activities: (1) immune checkpoint regulation via canonical translocation; (2) aberrant calcium signaling; and (3) noncanonical mechanisms independent of channel functions. We further delineate the pan-cancer expression and CRISPR-Cas9 dependency landscape, highlighting a dual“high expression, high dependency” profile in cervical squamous cell carcinoma. We distinguish current pore-targeting Sec61 inhibitors from subunit-specific strategies and propose future directions including PROTAC degraders and PPI inhibitors. Our review identifies SEC61G as a pan‑cancer prognostic biomarker and immunotherapy response predictor, with mechanistic evidence supporting its driver roles in glioblastoma, non‑small cell lung cancer, and colorectal cancer, whereas associations in other cancers remain correlative and require further validation.  \nARTICLE HISTORY  \nReceived 27 April 2026 Revised 11 June 2026 Accepted 19 June 2026  \nKEYWORDS  \nSEC61G; Sec61 channel; pan-cancer; oncogenic mechanism; prognostic biomarker  \nIntroduction  \nThe Sec61 channel constitutes the principal gateway for the translocation of nascent polypeptides across the endoplasmic reticulum (ER) membrane. Its functional status directly regulates the ER protein-folding load and determines the activation threshold of the unfolded protein response. 1 During tumorigenesis, oncogene-driven increases in protein synthesis impose sustained translocation demand on the Sec61 channel. Although adaptive upregulation of channel activity can mitigate short-term stress, chronic hyperactivation results in irreversible disruption of ER homeostasis, thereby promoting malignant phenotypes, including apoptosis resistance, metabolic reprogramming, enhanced invasion, and metastasis.2-4 The Sec61 channel is a heterotrimeric complex composed of α (SEC61A1/A2), β (SEC61B), and γ(SEC61G) .5 SEC61A forms the central pore and contains 10 transmembrane helices, serving as the primary conduit for nascent polypeptides crossing the ER membrane. SEC61B is a single-pass transmembrane protein that contributes to channel assembly and stability. SEC61G, the smallest subunit, consists of 68 amino acids and a single transmembrane helix. It stabilizes the three-dimensional conformation of the channel through interactions with SEC61A and participates in regulating channel gating during protein translocation.6 Functional integrity of the Sec61 channel requires coordinated assembly of all three subunits; disruption of any component significantly impairs protein translocation efficiency.7 Moreover, studies have demonstrated that the Sec61 channel functions as a passive ER Ca²⁺ leakage pathway,  \ncontributing to calcium homeostasis between the ER and cytosol.8-10 Because SEC61G primarily contributes to channel assembly and regulation rather than direct substrate recognition, its independent biological significance has been historically underappreciated.  \nCONTACT Mao-Lin He  [hemaolin@stu.gxmu.edu.cn](hemaolin@stu.gxmu.edu.cn)  Division of Spinal Surgery, The First Affiliated Hospital of Guangxi Medical University,  Shuangyong Road, Nanning, 530021, Guangxi Zhuang Autonomous Region, People's Republic of China  \nContributor Information: Dr. Yu-Nan Man, [202","cbCaiihsxpRSlIaO","https://ap.wps.com/l/cbCaiihsxpRSlIaO","pdf",3105401,21,"English","# Introduction\n## Rationale for focusing on SEC61G\n## Oncogenic role across cancers\n# Abstract","[{\"question\":\"What is SEC61G and why is it important in cancer biology?\",\"answer\":\"SEC61G is the γ subunit of the Sec61 translocon. It has been linked to independent oncogenic functions across multiple cancers, not just as an EGFR co-amplification passenger.\"},{\"question\":\"How does the review classify SEC61G oncogenic mechanisms?\",\"answer\":\"It groups SEC61G activities into canonical immune checkpoint regulation via translocation, aberrant calcium signaling, and noncanonical mechanisms independent of channel functions.\"},{\"question\":\"What evidence does the review provide for SEC61G as a biomarker?\",\"answer\":\"The review highlights pan-cancer expression and CRISPR-Cas9 dependency, and describes mechanistic evidence supporting SEC61G as a prognostic biomarker and immunotherapy response predictor in glioblastoma, non-small cell lung cancer, and colorectal cancer.\"}]","Advances in SEC61G research - from ER translocon subunit to emerging pan-cancer oncogenic roles | PDF",1790083096,53,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b9f17fe195c05d6550d11c08258984e1.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2aa5c5428c780618087813647d95cf64.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ede4018e70ca685a230eeb1d4d66fd51.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3800919cc851ddbbdb97d377c34f9ab5.webp",980,1306]